Community-associated New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales: multiple states, from September 2021 through September 2022
In the United States, New Delhi metallo-beta-lactamase (NDM)-producing carbapenem-resistant Enterobacterales (CRE) are frequently associated with healthcare encounters. From September 2021 to September 2022, 21 patients with NDM-CRE identified from urine and without healthcare exposure were reported to the Centers for Disease Control and Prevention. Isolates were genetically similar to healthcare-associated strains.
Authors
- Shermalyn R. Greene (ORCID: https://orcid.org/0000-0001-9975-5398)
- Richard A. Stanton (ORCID: https://orcid.org/0000-0003-4810-7002)
- Samuel E Cincotta (ORCID: https://orcid.org/0000-0001-6872-1216)
- Jenna N. Sinkevitch
- Celina Santiago (ORCID: https://orcid.org/0000-0002-1536-964X)
- Marisa D’Angeli (ORCID: https://orcid.org/0000-0002-3512-9176)
- Maroya Spalding Walters (ORCID: https://orcid.org/0000-0002-1090-7621)
- Sophie Jones (ORCID: https://orcid.org/0000-0003-0350-2578)
- Kelley Garner
- Wei Wang
- Audrey Brezak
- Megan Sredl
- Trenton Gulley
Institutions
- Washington State Department of Health (US)
- NC Department of Health and Human Services (US)
- Pennsylvania Department of Health (US)
- New York City Department of Health and Mental Hygiene (US)
- Council of State and Territorial Epidemiologists (US)
- United States Public Health Service (US)
- National Center for Emerging and Zoonotic Infectious Diseases (US)
- Epidemic Intelligence Service (US)
- Arkansas Department of Health (US)
Publication Details
- Journal
- Infection Control and Hospital Epidemiology
- Published
- 2025-03-24
- DOI
- https://doi.org/10.1017/ice.2025.28
- Citations
- 2
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 1.18